IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group (Q73276250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Guillain–Barré syndrome

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

R Press

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Deretzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L P Zou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Zhu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Fredman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Link

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

129-138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Differential expression of gangliosides on the surfaces of myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Circulating adhesion molecules and inflammatory mediators in demyelination: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Different ceramide compositions of gangliosides between human motor and sensory nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

Cytokines and the pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900388-X

7 January 2021

10.1016/S0165-5728(00)00388-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108941%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference